STRATA Skin Sciences Inc represents a commitment to providing innovative dermatology solutions. Their corporate philosophy revolves around delivering advanced technologies and products to improve patient outcomes. With a focus on dermatology and aesthetic procedures, STRATA Skin Sciences Inc strives to enhance the quality of life for those dealing with skin conditions. By continuously investing in research and development, they aim to bring cutting-edge solutions to the market. Committed to patient satisfaction, STRATA Skin Sciences Inc aims to be a leader in the dermatology industry, offering effective and reliable treatment options for various skin conditions.

STRATA Skin Sciences Inc is primarily present in the United States and Europe. In the United States, the company has a strong presence in major cities like New York, Los Angeles, and Chicago. Additionally, STRATA Skin Sciences Inc has expanded its operations to various European countries such as Germany, France, Italy, and the United Kingdom. With a global reach, STRATA Skin Sciences Inc aims to provide its innovative dermatology products and services to a wide range of patients and healthcare professionals in these key markets.

STRATA Skin Sciences Inc has achieved several significant milestones. Firstly, the company successfully developed and launched XTRAC, a leading excimer laser technology used for treating psoriasis and other skin conditions. Additionally, STRATA Skin Sciences Inc received FDA clearance for XTRAC in 2000, further strengthening its position in the market. The company also expanded its presence globally by entering into strategic partnerships and distribution agreements to enhance the accessibility of its products. Moreover, STRATA Skin Sciences Inc achieved ISO 13485:2016 certification, demonstrating its commitment to quality and compliance in the medical device industry. These milestones showcase the company's dedication to advancing dermatology treatments and its continued growth in the healthcare sector.

STRATA Skin Sciences Inc, previously known as MELA Sciences Inc, is a leading medical technology company specializing in dermatology and skin care products. Established in 1989, STRATA Skin Sciences has been committed to providing innovative solutions for various skin conditions. The company's flagship product, XTRAC, is a highly effective FDA-cleared excimer laser system used in the treatment of psoriasis and vitiligo. With a strong focus on research and development, STRATA Skin Sciences has revolutionized the field of dermatology by introducing cutting-edge technologies and therapies. Today, the company continues to strive towards advancing skin health and improving patients' lives.

The main competitors of STRATA Skin Sciences Inc in the market include companies such as Galderma Laboratories, Lumenis Ltd, and Cutera Inc.

STRATA Skin Sciences Inc is primarily active in the medical technology industry, specifically focused on developing and commercializing innovative solutions for dermatology and aesthetics.

The business model of STRATA Skin Sciences Inc focuses on providing innovative medical devices and solutions for various dermatological conditions. They develop and market advanced technologies, including the XTRAC Excimer Laser and the STRATAPEN MicroSystem, designed to treat psoriasis, vitiligo, and other skin disorders. STRATA Skin Sciences Inc's business strategy revolves around leveraging its scientific expertise to enhance patient outcomes and expand market reach through a combination of direct sales, partnerships, and international distribution networks. With their commitment to advancing dermatology and delivering effective solutions, STRATA Skin Sciences Inc aims to address the medical needs of patients worldwide.

STRATA Skin Sciences P/E suhe on −1,08.

STRATA Skin Sciences KUV on 0,34.

AlleAktien kvaliteediskoor ettevõttele STRATA Skin Sciences on 4/10.

oodatud STRATA Skin Sciences käive on 31,78 mln. USD.

oodatud STRATA Skin Sciences kasum on −10,02 mln. USD.

STRATA Skin Sciences Inc is an innovative company specialized in developing and marketing advanced medical devices for dermatology. They offer a wide range of products and services to assist dermatologists and skincare experts in efficiently and effectively treating and healing skin problems. One of STRATA Skin Sciences' main products is the XTRAC laser therapy. This innovative device uses ultraviolet radiation to treat skin conditions such as psoriasis, vitiligo, and eczema. Its precise application allows affected areas of the skin to be treated quickly without damaging healthy skin, which is not possible with many competitors on the market. The XTRAC laser therapy is undoubtedly one of STRATA Skin Sciences' flagship products, successfully marketed internationally. In addition to the XTRAC laser therapy, STRATA Skin Sciences also offers other technologies for the dermatology industry, such as the STRATAFIX technology used for wound treatment and healing. In addition to these medical devices, the company also provides dermatologists and their patients with access to a wide range of skincare products and creams to care for the skin after treatment. STRATA Skin Sciences has also specialized in telemedicine, which is very convenient for patients. Dermatologists can remotely monitor their patients to minimize the risk of infection in clinics or medical practices. Telemedicine allows specialists to monitor the patient's health and make adjustments to the treatment if necessary. STRATA Skin Sciences' business model is focused on providing a comprehensive range of products and services to meet all the needs of dermatologists and their patients. The company also operates a research and development department to continuously work on developing promising technologies and products to achieve the best possible results for patients. As a leading provider of medical devices for skincare and treatment, STRATA Skin Sciences Inc strives to constantly improve the quality of its products and services. They work closely with top dermatologists and scientists to provide state-of-the-art technologies and products to treat skin problems more effectively and cost-efficiently. Overall, STRATA Skin Sciences is a successful and innovative company dedicated to providing high-quality products and services for healthcare professionals, patients, and the general population. With many years of experience and expertise in dermatology, STRATA Skin Sciences has achieved a leading position in the market, allowing them to continue to grow and provide valuable solutions for treating skin diseases.

STRATA Skin Sciences maksab dividendi 0 USD, mis jaotatakse väljamakse peale aasta jooksul.

Dividendi ei saa praegu STRATA Skin Sciences jaoks arvutada või ettevõte ei maksa dividende välja.

STRATA Skin Sciences ISIN on US86272A2069.

STRATA Skin Sciences WKN on A2DQVU.

STRATA Skin Sciences tähis on SSKN.

Viimase 12 kuu jooksul maksis STRATA Skin Sciences dividendi suuruses . See vastab ligikaudu dividenditootlusele. Järgneva 12 kuu jooksul maksab STRATA Skin Sciences tõenäoliselt dividendi summas 0 USD.

STRATA Skin Sciences praegune dividenditootlus on .

STRATA Skin Sciences maksab kvartaalset dividendi. See makstakse välja kuudel .

STRATA Skin Sciences maksis viimase 0 aasta jooksul igal aastal dividendi.

Järgmise 12 kuu jooksul oodatakse dividende summas 0 USD. See vastab dividenditootlusele 0 %.

STRATA Skin Sciences on liigitatud sektorisse 'Tervis'.

Viimase STRATA Skin Sciences dividendide saamiseks 7.7.2024 suuruses 0 USD pidid sul olema aktsiaid portfellis enne eks-dividendi päeva 7.7.2024.

Viimane dividendimakse toimus 7.7.2024.

Aastal 2023 maksis STRATA Skin Sciences 0 USD dividende.

STRATA Skin Sciences dividendid makstakse välja USD.